BioCentury | Mar 5, 2021
Deals

March 4 Quick Takes: Crossovers pour into Amunix’s $117M B round; plus funding for atai, BlossomHill, OnKure, Exscientia, CorVista, Blue Note and Geneos and deals for Takeda-Enzyre, ConserV-eTheRNA

...led by Viking Global Investors with participation by new investors Bain Capital Life Sciences, BlackRock, Franklin Templeton...
BioCentury | Feb 27, 2021
Deals

Feb. 26 Quick Takes: Venrock leads Artiva’s crossover-laden $120M series B; plus Roivant-Silicon, Origin, Sino-Akeso, Tricida, LISCure

...Healthcare Capital Partners. Other new investors participating included Acuta Capital Partners, Cormorant Asset Management, EcoR1 Capital, Franklin Templeton...
BioCentury | Feb 16, 2021
Finance

Medicxi, blue chip investors launch Centessa with $250M to take asset-centric companies further

...Price Associates, Inc., Venrock Healthcare Capital Partners, Wellington Management Company, BVF Partners L.P., EcoR1 Capital, Franklin Templeton...
...Price Associates, Inc., Venrock Healthcare Capital Partners, Wellington Management Company, BVF Partners L.P., EcoR1 Capital, Franklin Templeton...
BioCentury | Feb 12, 2021
Deals

Feb. 11 Quick Takes: First day pop for Bioventus; plus venture rounds for Pipeline, Immunai, Sanofi, i2O, AZ’s trimmings, Truveta

...raised $80 million in a series C round, with participation by new investors including Perceptive Advisors, Franklin Templeton...
BioCentury | Feb 11, 2021
Product Development

With $130M series B, Day One explores new pediatric cancer targets as it prepares for launch

...round, which also included Boxer Capital, BVF Partners, Franklin Templeton...
BioCentury | Aug 11, 2020
Finance

Aug. 10 Quick Takes: Megarounds for Lepu, Dyne; plus CureVac’s IPO plans, top marks for Chinese biotech trio and more

...muscular dystrophy (DMD) and facioscapulohumeral muscular dystrophy. The round’s investors also included Wellington Management Company, Logos Capital, Franklin Templeton...
BioCentury | Jun 5, 2020
Finance

With $85M series B, Athira seeks to recover neuronal health in Alzheimer’s patients

...Inc.’s round, which included new investors RTW Investments, Viking Global Investors, Venrock Healthcare Capital Partners, Franklin Templeton...
BioCentury | Mar 18, 2020
Finance

March 17 Quick Takes: Tempus, Circle, Immatics, Exuma, CFIUS

...raised by the company to over $600 million since its founding in 2015. Baillie Gifford, Franklin Templeton...
BioCentury | Oct 8, 2019
Company News

After remedies to NDA, Intarcia’s diabetes implant under FDA review again

...Associates, New Leaf Venture Partners, Venrock, Farallon Capital, the Baupost Group, RA Capital, Foresite Capital, Franklin Templeton...
BioCentury | May 30, 2019
Financial News

May 30 Financial Quick Takes: $200M series F for Tempus; plus TFF, Frontage Holdings

...its money raised since being founded in 2015. Participating in the round were Baillie Gifford, Franklin Templeton...
Items per page:
1 - 10 of 101
BioCentury | Mar 5, 2021
Deals

March 4 Quick Takes: Crossovers pour into Amunix’s $117M B round; plus funding for atai, BlossomHill, OnKure, Exscientia, CorVista, Blue Note and Geneos and deals for Takeda-Enzyre, ConserV-eTheRNA

...led by Viking Global Investors with participation by new investors Bain Capital Life Sciences, BlackRock, Franklin Templeton...
BioCentury | Feb 27, 2021
Deals

Feb. 26 Quick Takes: Venrock leads Artiva’s crossover-laden $120M series B; plus Roivant-Silicon, Origin, Sino-Akeso, Tricida, LISCure

...Healthcare Capital Partners. Other new investors participating included Acuta Capital Partners, Cormorant Asset Management, EcoR1 Capital, Franklin Templeton...
BioCentury | Feb 16, 2021
Finance

Medicxi, blue chip investors launch Centessa with $250M to take asset-centric companies further

...Price Associates, Inc., Venrock Healthcare Capital Partners, Wellington Management Company, BVF Partners L.P., EcoR1 Capital, Franklin Templeton...
...Price Associates, Inc., Venrock Healthcare Capital Partners, Wellington Management Company, BVF Partners L.P., EcoR1 Capital, Franklin Templeton...
BioCentury | Feb 12, 2021
Deals

Feb. 11 Quick Takes: First day pop for Bioventus; plus venture rounds for Pipeline, Immunai, Sanofi, i2O, AZ’s trimmings, Truveta

...raised $80 million in a series C round, with participation by new investors including Perceptive Advisors, Franklin Templeton...
BioCentury | Feb 11, 2021
Product Development

With $130M series B, Day One explores new pediatric cancer targets as it prepares for launch

...round, which also included Boxer Capital, BVF Partners, Franklin Templeton...
BioCentury | Aug 11, 2020
Finance

Aug. 10 Quick Takes: Megarounds for Lepu, Dyne; plus CureVac’s IPO plans, top marks for Chinese biotech trio and more

...muscular dystrophy (DMD) and facioscapulohumeral muscular dystrophy. The round’s investors also included Wellington Management Company, Logos Capital, Franklin Templeton...
BioCentury | Jun 5, 2020
Finance

With $85M series B, Athira seeks to recover neuronal health in Alzheimer’s patients

...Inc.’s round, which included new investors RTW Investments, Viking Global Investors, Venrock Healthcare Capital Partners, Franklin Templeton...
BioCentury | Mar 18, 2020
Finance

March 17 Quick Takes: Tempus, Circle, Immatics, Exuma, CFIUS

...raised by the company to over $600 million since its founding in 2015. Baillie Gifford, Franklin Templeton...
BioCentury | Oct 8, 2019
Company News

After remedies to NDA, Intarcia’s diabetes implant under FDA review again

...Associates, New Leaf Venture Partners, Venrock, Farallon Capital, the Baupost Group, RA Capital, Foresite Capital, Franklin Templeton...
BioCentury | May 30, 2019
Financial News

May 30 Financial Quick Takes: $200M series F for Tempus; plus TFF, Frontage Holdings

...its money raised since being founded in 2015. Participating in the round were Baillie Gifford, Franklin Templeton...
Items per page:
1 - 10 of 101